BIAF Stock Catalyst: bioAffinity Technologies Announces Nationwide Federal Healthcare Distribution Agreement for CyPath® Lung with AvMEDICAL

Aug 18, 2026 · 8:00am ET

The agreement covers the distribution of CyPath® Lung across federal healthcare facilities.

Max move

+61.2%

High of day $9.43

Sparker timei

8:00am ET

BIAF · Aug 18, 2026

CATALYST DATE · 1-MINUTE BARS

Catalyst Summary

bioAffinity Technologies, Inc. (Nasdaq: BIAF) and AvMEDICAL have announced a nationwide distribution agreement for CyPath® Lung. This agreement will enable the distribution of CyPath® Lung, a diagnostic tool, across federal healthcare facilities.

The collaboration leverages AvMEDICAL's extensive network to provide bioAffinity's innovative diagnostic solution to a broader patient population within the federal healthcare system.

This summary was generated by AI from public sources and may contain errors. Not financial advice. Trade at your own risk.

Real-time alerts

Get notified the next time BIAF sparks.

Download Sniper App →

Catch the next BIAF-style move in real time.

Day Trader Sniper alerts you the moment a setup like this triggers: premarket, open, or intraday.

Watch demo Download Free →